$44.75
-0.42-0.93%
近くで: Sep 25, 5:00 PM EST
$44.75
N/A
時間外: Sep 25, 4:00 PM EST
Benzinga
Benzinga
Benzinga
日曜日, 9 27
Enliven Therapeutics Inc
ELVNNASDAQ
Enliven Therapeutics Earnings & Forecasts
Enliven Therapeutics (ELVN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Enliven Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.37 | $-0.42 | $-0.45 | $-0.45 |
| Actual | $-0.49 | $-0.38 | $-0.48 | $-0.32 |
| Surprise | -32.4% | +9.52% | -6.67% | +28.9% |
| Revenue | ||||
| Estimate | — | $10000 | $10000 | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | -100.0% | -100.0% | — |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.44 | $-0.58 |
| Revenue | ||
| Consensus | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved